131 related articles for article (PubMed ID: 20074910)
1. Effects of bone morphogenetic protein-2 on proliferation and angiogenesis in oral squamous cell carcinoma.
Gao Q; Tong W; Luria JS; Wang Z; Nussenbaum B; Krebsbach PH
Int J Oral Maxillofac Surg; 2010 Mar; 39(3):266-71. PubMed ID: 20074910
[TBL] [Abstract][Full Text] [Related]
2. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
[TBL] [Abstract][Full Text] [Related]
3. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
4. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
Harada K; Supriatno ; Yoshida H; Sato M
Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human bone morphogenetic protein-2 promotes the proliferation of mesenchymal stem cells in vivo and in vitro.
Liu SB; Hu PZ; Hou Y; Li P; Cao W; Tian Q
Chin Med J (Engl); 2009 Apr; 122(7):839-43. PubMed ID: 19493400
[TBL] [Abstract][Full Text] [Related]
6. Expression level of vascular endothelial growth factor-C and -A in cultured human oral squamous cell carcinoma correlates respectively with lymphatic metastasis and angiogenesis when transplanted into nude mouse oral cavity.
Nakazato T; Shingaki S; Kitamura N; Saito C; Kuwano R; Tachibana M
Oncol Rep; 2006 Apr; 15(4):825-30. PubMed ID: 16525666
[TBL] [Abstract][Full Text] [Related]
7. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
[TBL] [Abstract][Full Text] [Related]
8. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells.
Langenfeld EM; Calvano SE; Abou-Nukta F; Lowry SF; Amenta P; Langenfeld J
Carcinogenesis; 2003 Sep; 24(9):1445-54. PubMed ID: 12819188
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation.
Fromigué O; Marie PJ; Lomri A
J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905
[TBL] [Abstract][Full Text] [Related]
10. The effects of recombinant human bone morphogenetic protein-2, recombinant human bone morphogenetic protein-12, and adenoviral bone morphogenetic protein-12 on matrix synthesis in human annulus fibrosis and nucleus pulposus cells.
Gilbertson L; Ahn SH; Teng PN; Studer RK; Niyibizi C; Kang JD
Spine J; 2008; 8(3):449-56. PubMed ID: 18455111
[TBL] [Abstract][Full Text] [Related]
11. Segmental bone regeneration using an rhBMP-2-loaded gelatin/nanohydroxyapatite/fibrin scaffold in a rabbit model.
Liu Y; Lu Y; Tian X; Cui G; Zhao Y; Yang Q; Yu S; Xing G; Zhang B
Biomaterials; 2009 Oct; 30(31):6276-85. PubMed ID: 19683811
[TBL] [Abstract][Full Text] [Related]
12. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes.
Park J; Ries J; Gelse K; Kloss F; von der Mark K; Wiltfang J; Neukam FW; Schneider H
Gene Ther; 2003 Jul; 10(13):1089-98. PubMed ID: 12808439
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors.
Langenfeld EM; Langenfeld J
Mol Cancer Res; 2004 Mar; 2(3):141-9. PubMed ID: 15037653
[TBL] [Abstract][Full Text] [Related]
14. S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2.
Harada K; Supriatno ; Kawashima Y; Yoshida H; Sato M
Int J Oncol; 2007 Feb; 30(2):365-74. PubMed ID: 17203218
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.
Hoffmann S; Rockenstein A; Ramaswamy A; Celik I; Wunderlich A; Lingelbach S; Hofbauer LC; Zielke A
Mol Cell Endocrinol; 2007 Jan; 264(1-2):74-81. PubMed ID: 17101211
[TBL] [Abstract][Full Text] [Related]
16. Bone formation following transplantation of genetically modified primary bone marrow stromal cells.
Sugiyama O; Orimo H; Suzuki S; Yamashita K; Ito H; Shimada T
J Orthop Res; 2003 Jul; 21(4):630-7. PubMed ID: 12798062
[TBL] [Abstract][Full Text] [Related]
17. Off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) for reconstruction of mandibular bone defects in humans.
Carter TG; Brar PS; Tolas A; Beirne OR
J Oral Maxillofac Surg; 2008 Jul; 66(7):1417-25. PubMed ID: 18571026
[TBL] [Abstract][Full Text] [Related]
18. [In vitro osteogenesis of the compound of chitosan and recombinant human bone morphogenetic protein 2].
Liang D; Zuo A; Wang B; Zhang J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Sep; 19(9):721-4. PubMed ID: 16206761
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
J Oral Maxillofac Surg; 2007 Jan; 65(1):17-21. PubMed ID: 17174758
[TBL] [Abstract][Full Text] [Related]
20. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
